Rapid phagosome formation drives parasite control in subclinical Leishmania braziliensis infection - Scorecard - MDSpire

Rapid phagosome formation drives parasite control in subclinical Leishmania braziliensis infection

  • By

  • Caic Figueiredo

  • Alan Rocha dos Santos

  • Camila Pimentel

  • Maurício T. Nascimento

  • Fabio Peixoto

  • Vítor Oliveira

  • Olivia Bacellar

  • Lucas P. Carvalho

  • Edgar M. Carvalho

  • Thiago M. Cardoso

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: Accelerated Formation of Phagosomes Enhances Control of Parasites in Asymptomatic Leishmania braziliensis Infections

At a Glance

CategoryDetail
ConditionCutaneous leishmaniasis (CL) caused by Leishmania braziliensis
Key MechanismsPhagosome formation and intracellular parasite control by macrophages
Target PopulationIndividuals with subclinical (SC) L. braziliensis infection
Care SettingEndemic areas of L. braziliensis transmission

Key Highlights

  • SC macrophages exhibit quicker phagosome formation compared to CL macrophages.
  • Effective control of L. braziliensis infection observed in SC individuals.
  • Lower levels of IFN-γ and TNF-α produced by SC individuals compared to CL subjects.
  • SC individuals do not develop clinical leishmaniasis despite positive Leishmania skin test.
  • Macrophages from SC individuals maintain effective parasite killing despite lower oxidative burst.

Guideline-Based Recommendations

Diagnosis

  • Positive Leishmania skin test (LST) and/or IFN-γ production upon exposure to soluble Leishmania antigen (SLA) for SC individuals.

Management

  • Monitor SC individuals for potential development of CL while recognizing their effective control of infection.

Monitoring & Follow-up

  • Evaluate levels of pro-inflammatory cytokines in PBMCs from SC and CL subjects.

Risks

  • Risk of developing CL in individuals with SC infection remains, necessitating ongoing surveillance.

Patient & Prescribing Data

Individuals with subclinical L. braziliensis infection

SC individuals control infection without developing pathology.

Clinical Best Practices

  • Encourage monitoring of immune responses in SC individuals.
  • Consider the role of macrophage function in the management of leishmaniasis.
  • Utilize flow cytometry to assess phagosome formation and parasite control.

Related Resources & Content

Original Source(s)

Related Content